1. Home
  2. SFST vs AURA Comparison

SFST vs AURA Comparison

Compare SFST & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern First Bancshares Inc.

SFST

Southern First Bancshares Inc.

SELL

Current Price

$60.27

Market Cap

562.5M

Sector

Finance

ML Signal

SELL

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

SELL

Current Price

$7.23

Market Cap

631.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SFST
AURA
Founded
1999
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
562.5M
631.6M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SFST
AURA
Price
$60.27
$7.23
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
★ $68.75
$16.60
AVG Volume (30 Days)
69.8K
★ 741.8K
Earning Date
10-20-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 94.76
N/A
EPS
★ 3.68
N/A
Revenue
★ $6,282,000.00
N/A
Revenue This Year
$23.97
N/A
Revenue Next Year
$17.69
N/A
P/E Ratio
$16.45
★ N/A
Revenue Growth
★ 12.99
N/A
52 Week Low
$47.01
$4.73
52 Week High
$65.09
$9.54

Technical Indicators

Market Signals
Indicator
SFST
AURA
Relative Strength Index (RSI) 47.40 58.42
Support Level $58.42 $6.65
Resistance Level $63.05 $7.83
Average True Range (ATR) 1.68 0.42
MACD -0.02 0.10
Stochastic Oscillator 26.06 63.68

Price Performance

Historical Comparison
SFST
AURA

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. Through its banking subsidiary, it is engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer, and mortgage loans, ATM processing, and other banking products and services to the general public. The group operates through various retail offices located in the Greenville, Columbia, and Charleston markets of South Carolina, three retail offices in the Raleigh, Greensboro, and Charlotte markets of North Carolina, and one retail office in Atlanta, Georgia.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: